AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00334-06v1
51/2/744    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tam, V. H.
Right arrow Articles by Drusano, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, V. H.
Right arrow Articles by Drusano, G. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2007, p. 744-747, Vol. 51, No. 2
0066-4804/07/$08.00+0     doi:10.1128/AAC.00334-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance{triangledown}

Vincent H. Tam,* Arnold Louie, Mark R. Deziel,{dagger} Weiguo Liu, and George L. Drusano

Emerging Infections and Host Defense Laboratory, Ordway Research Institute, Albany, New York

Received 17 March 2006/ Returned for modification 9 August 2006/ Accepted 31 October 2006

We determined the relationship between garenoxacin exposure and quinolone-resistant subpopulations for three bacterial isolates in an in vitro hollow-fiber infection model. An "inverted-U" relationship was identified wherein resistant subpopulations rose initially and then declined with increasing exposure, until reaching a threshold that prevented resistance amplifications. Different targets for the area under the concentration-time curve over 24 h/MIC ratio were required for different bacteria.

* Corresponding author. Mailing address: University of Houston College of Pharmacy, 1441 Moursund St., Houston, TX 77030. Phone: (713) 795-8316. Fax: (713) 795-8383. E-mail: vtam{at}uh.edu.

{triangledown} Published ahead of print on 20 November 2006.

{dagger} Deceased.

Antimicrobial Agents and Chemotherapy, February 2007, p. 744-747, Vol. 51, No. 2
0066-4804/07/$08.00+0     doi:10.1128/AAC.00334-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.